Hyphens Pharma International Ltd. · SGX:1J5
Hyphens Pharma International — Q1 2023 Earnings Presentation
9 slides from Hyphens Pharma International's earnings presentation, May 15, 2023
Slide 1: Hyphens Pharma International Limited Results Briefing 1Q2023
HYPHENS PHARMA INTERNATIONAL LIMITED Results Briefing 1Q2023 15 May 2023
Slide 2: Disclaimer
DISCLAIMER This presentation has been prepared by Hyphens Pharma International Limited (the "Company" and, together with its subsidiaries, the "Group"). This content in this presentation is being furnished to you on a confidential basis and solely for your information and neither this presentation n
Slide 3: Financial Results
Singapore's Leading Specialty Pharmaceutical and Consumer Healthcare Group g Hyphens
Slide 4: 1.1 Financial Performance
1.1 FINANCIAL PERFORMANCE Revenue (S$'mil) Profit After Tax (S$'mil) 42.8 41.5 4.0 39.2 38.8 33.2 3.2 3.0 1.4 1.1 1Q2022 2Q2022 3Q2022 4Q2022 1Q2023 1Q2022 2Q2022 3Q2022 4Q2022 1Q2023
Slide 5: 1.2 Financial Highlights
1.2 FINANCIAL HIGHLIGHTS S$’000 1Q2023 1Q2022 QoQ Revenue 33,234 39,168 (15.2%) Gross Profit 13,115 15,024 (12.7%) Profit before tax 1,616 4,183 (61.4%) Profit after tax 1,379 3,198 (56.9%)
Slide 6: Business Outlook
Singapore's Leading Specialty Pharmaceutical and Consumer Healthcare Group g Hyphens
Slide 7: Our Growth Strategy
OUR GROWTH STRATEGY 1. Growing our proprietary brands 2. Going Digital 3. Expanding through acquisitions 4. Strengthening specialty pharma portfolio
Slide 8: Questions & Answers
Singapore's Leading Specialty Pharmaceutical and Consumer Healthcare Group g Hyphens
Slide 9: Hyphens Pharma International Limited (SGX: 1J5)
Hyphens Pharma International Limited (SGX: 1J5) 16 Tai Seng Street, Level 4, Singapore 534138 www.hyphensgroup.com
Hyphens Pharma International — Q1 2023 Earnings Presentation on 6ix